Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year. Currently, the only potential treatment for this condition is liver transplantation, which is available to very few patients. A first-in-human randomized controlled clinical trial using DIALIVE, a novel liver dialysis device, demonstrated its potential as a disease-modifying therapy and resolved liver failure significantly faster and in a greater p.
Leading voices confirmed include:
George Paraskevakos, Executive Director, IPA (International Probiotics Association)
Elaine Patterson, Senior Scientist and Technical Lead of the Brain Health Platform at DuPont Nutrition & Biosciences.
Udo Herz, Medical and Science Director at Danone Nutricia Specialized Nutrition
Daniel Ramón Vidal, PhD, Vice President, R&D Health & Wellness at ADM
Dr Zain M Saiyed, Associate Director, R&D, Ingredients Innovation, Lonza Capsules & Health Ingredients
Dr Luis Gosalbez, Managing Director and co-founder at Sandwalk Bioventures
Dr Orla O’Sullivan, Senior Research Officer at Teagasc Food Research Centre
Dr Vanessa Stadlbauer, Clinical gastroenterologist & hepatologist and associate professor at the Medical University of Graz
Leading voices confirmed include:
George Paraskevakos, Executive Director, IPA (International Probiotics Association)
Elaine Patterson, Senior Scientist and Technical Lead of the Brain Health Platform at DuPont Nutrition & Biosciences.
Udo Herz, Medical and Science Director at Danone Nutricia Specialized Nutrition
Daniel Ramón Vidal, PhD, Vice President, R&D Health & Wellness at ADM
Dr Zain M Saiyed, Associate Director, R&D, Ingredients Innovation, Lonza Capsules & Health Ingredients
Dr Luis Gosalbez, Managing Director and co-founder at Sandwalk Bioventures
Dr Orla O’Sullivan, Senior Research Officer at Teagasc Food Research Centre
Dr Vanessa Stadlbauer, Clinical gastroenterologist & hepatologist and associate professor at the Medical University of Graz
In a little over three weeks’ time NutraIngredients will once again bring together the very best microbiome researchers and global business leaders as Probiota goes online for the first time.